Cytokine Storm Syndromes: Immune Dysregulation in Severe Viral Infections and Autoimmune Diseases

Cytokine storm syndromes (CSS) are characterized by an excessive and uncontrolled release of pro-inflammatory cytokines, leading to systemic inflammation and multi-organ dysfunction. Initially recognized in severe viral infections, such as those caused by SARS-CoV-2 and H1N1, CSS have also been implicated in various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. This review explores the pathophysiology of CSS, highlighting the critical roles of key cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) in driving hyper-inflammatory responses. We discuss the triggers of cytokine storms, including viral infections, autoimmune dysregulation, genetic predispositions, and therapeutic agents. Clinical manifestations can range from mild symptoms to severe complications, including acute respiratory distress syndrome (ARDS) and septic shock. Early recognition and intervention are vital for improving outcomes. Management strategies focus on mitigating inflammation through corticosteroids, monoclonal antibodies, and Janus kinase (JAK) inhibitors. As research advances, a deeper understanding of the mechanisms underlying cytokine storm syndromes will pave the way for innovative therapeutic approaches, enhancing patient care in these critical and complex conditions. Keywords: Cytokine Storm Syndromes (CSS), Pro-inflammatory Cytokines, SARS-CoV-2, Autoimmune Diseases, Acute Respiratory Distress Syndrome (ARDS), Therapeutic Strategies